Speaker illustration

Doctor Ryo Kurosawa

Tohoku University, Sendai (Japan)

Member of:

European Society of Cardiology

Identification of celastramycin as a novel therapeutic agent for pulmonary arterial hypertension -high-throughput screening of 5,562 compounds-

Event: ESC Congress 2019

Topic: Hypertension, Pulmonary Hypertension

Session: Novel pharmacological targets in vascular disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb